Check out our most popular compounded medications! Get Started
Our Desmopressin Acetate 0.2 mg/5 mL Oral Liquid is a meticulously prepared medication designed for oral use. This liquid formulation ensures precise dosing and ease of administration, particularly beneficial for patients who experience difficulty swallowing pills, such as children and the elderly. Desmopressin is commonly used in the management of diabetes insipidus, a condition characterized by frequent urination and excessive thirst. Additionally, it is employed in the treatment of bedwetting (nocturnal enuresis) and to address bleeding disorders like von Willebrand's disease and mild hemophilia A, where it helps to control bleeding episodes.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Desmopressin Acetate 0.2 mg/5 mL Oral Liquid is a meticulously prepared medication designed for oral use, offering a precise and manageable method for administering the active drug. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills or tablets, such as children and the elderly, or for those with conditions that impair their ability to ingest solid forms of medication. The liquid form ensures that the medication can be accurately measured to provide the exact prescribed dose, enhancing the safety and efficacy of the treatment.
Desmopressin Acetate is a synthetic analogue of the naturally occurring antidiuretic hormone vasopressin. It is primarily used in the management of central diabetes insipidus, a condition characterized by excessive thirst and the excretion of large amounts of diluted urine due to a deficiency of vasopressin. By mimicking the action of vasopressin, Desmopressin Acetate reduces urine output and increases urine concentration. Additionally, this medication is employed in the treatment of nocturnal enuresis (bedwetting) in children, as it can decrease the volume of urine produced at night. Desmopressin is also used in patients with mild forms of hemophilia A and von Willebrand's disease Type I, where it can promote the release of von Willebrand factor and factor VIII, thereby aiding in the control of bleeding episodes.
It is crucial for prescribers to consider the patient's medical history, current medications, and the potential for hyponatremia, a condition associated with low sodium levels that can occur with Desmopressin therapy. Monitoring of serum sodium levels may be necessary, especially in patients at risk for electrolyte imbalances. The oral liquid formulation allows for flexible dosing adjustments to meet individual patient needs and to minimize the risk of side effects. Patients and caregivers should be instructed on how to measure and administer the liquid correctly, and they should be aware of the signs and symptoms of hyponatremia, such as headache, nausea, confusion, and in severe cases, seizures.
Bayview Pharmacy's team of compounding pharmacists ensures that each batch of Desmopressin Acetate 0.2 mg/5 mL Oral Liquid is prepared with the highest standards of quality and precision. We are committed to providing personalized care and are available to answer any questions or concerns regarding this formulation. If you require further information or guidance on the use of Desmopressin Acetate Oral Liquid, please do not hesitate to reach out to us.
Desmopressin Acetate is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. It is used primarily for the treatment of central diabetes insipidus, for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region, and for primary nocturnal enuresis. Desmopressin is also used in tests of renal function and in the management of bleeding in patients with hemophilia A and von Willebrand's disease (Type I).
When considering the use of Desmopressin Acetate 0.2 mg/5 mL Oral Liquid, it is important to be aware of potential drug interactions that may affect the efficacy and safety of the medication. Desmopressin should be used with caution in patients receiving drugs that may increase the risk of water retention and/or hyponatremia, such as tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), chlorpromazine, opiate analgesics, NSAIDs, lamotrigine, and carbamazepine. These drugs can potentiate the antidiuretic effect of desmopressin, leading to an increased risk of water intoxication with hyponatremia.
Concomitant use of desmopressin with glucocorticoids can result in reduced efficacy of desmopressin, as glucocorticoids can increase urine volume and decrease the response to ADH. Patients on glucocorticoid therapy may require adjustments in their desmopressin dosage. Additionally, the use of desmopressin with fludrocortisone or other drugs that may lead to an increase in blood pressure should be monitored closely, as desmopressin can induce fluid retention, which may exacerbate hypertension.
Patients receiving medications that may affect renal function, such as NSAIDs, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs), should be monitored for changes in renal function and fluid balance when starting or adjusting the dose of desmopressin. Nonsteroidal anti-inflammatory drugs (NSAIDs) can potentially increase the risk of water retention and hyponatremia when used concurrently with desmopressin.
Alcohol consumption should be limited or avoided while taking desmopressin, as alcohol can reduce the antidiuretic effect of the medication, decreasing its efficacy. Additionally, patients should be advised to monitor fluid intake to avoid water intoxication, especially when initiating therapy or increasing the dose of desmopressin.
It is also important to consider the potential for an interaction with other drugs that have antidiuretic properties, such as vasopressin analogs, as the combination may lead to additive effects and increase the risk of water retention and hyponatremia.
Before prescribing Desmopressin Acetate 0.2 mg/5 mL Oral Liquid, it is essential to review the patient's current medication regimen for potential interactions. Adjustments to therapy may be necessary to ensure the safe and appropriate use of desmopressin. If you have any questions or require further information regarding drug interactions with desmopressin, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to both patients and prescribers.
Desmopressin Acetate is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. It is prescribed primarily for the treatment of central diabetes insipidus, a condition characterized by excessive thirst and excretion of large amounts of diluted urine, as well as for managing the symptoms of certain types of bedwetting (nocturnal enuresis) and for patients with hemophilia A and von Willebrand's disease (Type I) during surgical procedures to improve hemostasis.
The 0.2 mg/5 mL oral liquid formulation of Desmopressin Acetate provides a precise concentration that allows for accurate dosing tailored to the needs of the individual patient. When ingested, Desmopressin works by mimicking the action of natural ADH, which binds to receptors in the kidneys to promote reabsorption of water into the bloodstream, thereby reducing urine output. In patients with central diabetes insipidus, Desmopressin replaces the deficient ADH, helping to restore balance and reduce symptoms. For nocturnal enuresis, it decreases nocturnal urine production, and for patients with bleeding disorders, it can enhance the release of von Willebrand factor and factor VIII, which are important for blood clotting.
The oral liquid form is particularly beneficial for patients who have difficulty swallowing pills, such as young children or the elderly, and for those who require a flexible dosing regimen that can be easily adjusted. The liquid formulation ensures that the medication can be administered accurately with a dosing syringe or dropper, providing convenience and ease of use for both patients and caregivers.
It is important for prescribers to consider the specific needs of their patients when determining the appropriate dosage and to monitor for potential side effects, such as hyponatremia (low sodium levels), which can occur if water intake is not properly managed during treatment with Desmopressin. Additionally, the prescriber should review the patient's medical history to identify any contraindications or potential drug interactions.
For patients and prescribers interested in using this formulation of Desmopressin Acetate 0.2 mg/5 mL Oral Liquid, it is essential to understand the mechanism of action, the conditions it treats, and the benefits of the oral liquid dosage form. If you have any questions or require further information, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to support you with the knowledge and expertise to ensure appropriate treatment.
Desmopressin Acetate oral liquid is used to treat conditions that involve the inability to control urine production, such as central diabetes insipidus and bedwetting in children (nocturnal enuresis). It may also be prescribed to manage the symptoms of excessive thirst and urination caused by certain types of head injury or brain surgery.
This medication should be stored in a refrigerator, away from light and out of reach of children. Do not freeze the liquid, and ensure that the medication is kept in its original container with the cap tightly closed.
Individuals with a known allergy to desmopressin acetate or to any of the ingredients in the formulation should not take this medication. Additionally, it should not be used by patients with hyponatremia or history of hyponatremia, which is a low level of sodium in the blood, or those with syndromes of inappropriate secretion of antidiuretic hormone (SIADH).
Desmopressin Acetate Oral Liquid should be measured with the provided dosing syringe or another accurate measuring device. Gently shake the bottle before use, measure the prescribed dose, and administer the liquid by mouth following the instructions provided by your healthcare professional.
It is generally recommended to take Desmopressin Acetate Oral Liquid on an empty stomach, as food can affect the absorption of the medication. However, it is important to follow the specific direction provided by your doctor regarding food and medication intake.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up without consulting your healthcare provider.
Side effects from Desmopressin Acetate Oral Liquid may include headache, nausea, abdominal pain, or facial flushing. In rare cases, it may cause severe allergic reactions or hyponatremia. If you experience any side effects, you should immediately report them to your healthcare provider.
Yes, this medication can be prescribed to pediatric patients, especially in cases of nocturnal enuresis (bedwetting). The dosage will be determined by the child's medical condition and body weight, so it is crucial to follow the pediatrician's instructions closely.
The effects of Desmopressin Acetate Oral Liquid can usually be noticed within an hour of administration. The duration of effect can vary depending on the individual and should be discussed with your healthcare provider for better understanding and management of the condition being treated.
The safety of desmopressin acetate during pregnancy or breastfeeding has not been fully established. It's important to inform your healthcare provider if you are pregnant or plan to become pregnant, or if you are breastfeeding, so they can evaluate the potential risks and benefits of using this medication.
In case of an overdose, seek immediate medical attention. Symptoms of an overdose may include confusion, drowsiness, continuing headache, problems with passing urine, weight gain, and in severe cases, convulsions or breathing difficulties. The healthcare professionals can provide the necessary interventions for an overdose.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
